Meeting
2016 Palliative and Supportive Care in Oncology Symposium
Changes in opioid type and dose among cancer patients referred to outpatient palliative care.
Authors
Ali Haider
The University of Texas MD Anderson Cancer Center, Houston, TX
Ali Haider, Joseph Baidoo, Yee Choon Meng, Donna S. Zhukovsky, Kimberson Cochien Tanco, Holly A Stewart, Tonya Edwards, Manju P Joy, Leela Kuriakose, Zhanni Lu, Diane D Liu, Janet L. Williams, Eduardo Bruera
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Evaluation and Assessment of Patient Symptoms and Quality of Life,Integration and Delivery of Palliative Care in Cancer Care
Sub Track
Barriers to care across systems
Citation
J Clin Oncol 34, 2016 (suppl 26S; abstr 106)
DOI
10.1200/jco.2016.34.26_suppl.106
Abstract #
106
Poster Bd #
D10
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Persistent high-risk opioid use in lymphoma survivors following treatment.
First Author: Katherine Ann Stafford
Poster
2024 ASCO Breakthrough
Opioid access barriers for cancer pain relief in Vietnam: A qualitative study.
First Author: Trang Nguyen
Poster
2022 ASCO Quality Care Symposium
The association between medical cannabis and prescription opioid medication use in patients with early-stage cancer: A population-based study.
First Author: Safiya Karim
Poster
2019 Supportive Care in Oncology Symposium
Pharmacogenetic (PGx) guided cancer pain management in an oncology palliative medicine (PM) clinic.
First Author: Jai Narendra Patel